Treatment of Large Left Ventricular Aneurysm with Symptoms
Clinical Scenario
This protocol addresses patients with a large left ventricular (LV) aneurysm who are symptomatic. In this population, the management framework mirrors that of asymptomatic large LV aneurysm, with the critical addition of targeted treatment directed at the presenting complication or symptoms, and formal surgical evaluation where an indication exists.
Treatment Approach
Medical management begins with optimizing coronary artery disease risk factors, followed by measures to reduce ventricular afterload using specific agent classes; anticoagulation is also incorporated based on clinical timing and thrombus characteristics. The full regimen—including decision criteria, agent selection, and anticoagulation thresholds—is detailed in the complete protocol.
Complete algorithm, sequencing, and surgical criteria available in the full protocol below.
References
- In patients with large LV aneurysms with symptoms, the management is the same as asymptomatic cases, plus specific treatment for complication/symptoms treatment and perform surgical management if there is any indication.
- The management can include optimization of coronary artery disease risk factors for ischemia prevention, afterload reduction with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and anticoagulation to prevent thromboembolism.
- In terms of anticoagulation, the risk of LV mural thrombus is highest within the first month after acute infarction; therefore, it is always prudent to employ anticoagulation in all patients using warfarin the first three months after LV infarction.
- Long-term anticoagulation should be reserved for patients with large, friable thrombi protruding into the ventricular cavity, documented systemic embolization beyond the three months, or while receiving anticoagulants, and globally impaired LV function.
View source ↗